Skip to main content

Table 1 Patient information

From: Localized cytokine responses to total knee arthroplasty and total knee revision complications

ID

Sex

TKA/TKR

BMI (kg/m2)

Diabetic (Y/N)

CRP (mg/L)

Culture

P1

F

TKA

33.8

N

N/A

Negative

P2

F

TKA

39.8

N

N/A

Negative

P3

F

TKA

39.8

N

N/A

Negative

P4

M

TKA

29.7

Y

N/A

Negative

P5

M

TKA

24.6

N

N/A

Negative

P6

M

TKA

27.2

N

N/A

Negative

F1

F

TKR-aseptic

28.2

N

4.3

Negative

F2

F

TKR-aseptic

29.8

N

0.2

Negative

F3

F

TKR-aseptic

33.9

N

 < 1

Negative

F4

M

TKR-aseptic

40.4

Y

3.6

Negative

F5

M

TKR-aseptic

26.2

N

2.1

Negative

F6

F

TKR-septic

43.7

N

28.8

S. epidermidis

F7

F

TKR-septic

30.8

Y

161.4

S. epidermidis

F8

F

TKR-septic

41.9

N

21.7

E. cloacae

F9

M

TKR-septic

36.2

N

33.5

MSSA

F10

M

TKR-septic

33.8

Y

3.8

S. epidermidis

F11

M

TKR-septic

31.9

N

111.9

S. epidermidis

  1. Six primary TKA and 11 revision TKR patients were enrolled in the study, creating a heterogenous cohort of males and females varying in age (45–82 years) and comorbidities. Primary TKA patients have ID format P#; revision TKR patients have ID format F#. This table lists general patient information including the pathogen for which each septic patient tested culture-positive following testing on the day of surgery. Serum CRP values were obtained pre-operatively in the revision setting. Cultures were obtained from intraoperative tissue samples